Skip to content

BIOFLOW

Inactive KBO/BCE: BE 0672.700.839

Annual accounts 2021

abbreviated format, filed on 30-06-2022, 31 days before the deadline
-€317
-€7,918
▼ €7,470
-€7,927
▼ €7,377
-€4,032
▼ €2,358
-
-

Turnover and EBIT margin are not published. The abbreviated or micro format does not require them.

Balance sheet

balance sheet total €2,893 on 31-12-2021
What the company ownsHow it is paid for

in euro

in euro

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20212020201920182017
Balance sheet: assets
20/58 2,89312,06416,46030,79824,619
21/28 2,5009,8009,80014,07512,100
21 2,5009,8009,80014,07512,100
29/58 3932,2646,66016,72312,519
3 ---4,4103,180
30/36 ---4,4103,180
40/41 551,7611,9492,2507,752
40 ---2,2506,469
41 551,7611,949-1,283
54/58 3385034,71110,0631,587
Balance sheet: equity and liabilities
10/49 2,89312,06416,46030,79824,619
10/15 -36,534-28,607-28,057-11,6114,745
10/11 18,60018,60018,60018,60018,600
100 -18,60018,60018,60018,600
14 -55,134-47,207-46,657-30,211-13,855
17/49 39,42740,67144,51742,40819,874
17 35,00236,73339,57438,76216,252
178/9 35,00236,73339,57438,76216,252
42/48 4,4243,9384,9433,6473,623
44 4,2243,9384,7542,7233,623
440/4 4,2243,9384,7542,7233,623
45 200-188924-
450/3 200-188924-
Income statement
9900 -317--11,686-11,329-10,457
630 7,300-4,2754,2753,025
640/8 301448446681348
9901 -7,918-448-16,407-16,285-13,829
75/76B ---63-
75 ---63-
65/66B 91024013426
65 910240134-
66B ----26
9903 -7,927-550-16,446-16,356-13,855
9904 -7,927-550-16,446-16,356-13,855
9905 -7,927-550-16,446-16,356-13,855
Appropriation of the result
9906 -55,134-47,207-46,657-30,211-13,855
14P -47,207----
Document PDFPDFPDFPDFPDF

The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Source: Annual accounts 2021 (PDF), filed on 30-06-2022.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2021 abbreviated format 30-06-2022 2022-20127449 PDF
31-12-2020 micro format 27-06-2021 2021-26200459 PDF
31-12-2019 micro format 14-05-2020 2020-12200102 PDF
31-12-2018 abbreviated format 31-07-2019 2019-42400041 PDF
31-12-2017 micro format 28-08-2018 2018-53600383 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20212020201920182017
-618--12,132-12,010-10,804
-627--12,171-12,081-10,830
0-06,25015,125
-165-4,208-5,3528,476-
-4,032-1,6741,71713,0768,897
--237.1%-170.5%-37.7%19.3%
-0.571.354.593.46
-0.571.353.382.58
----4.19
-----292.0%
--4.6%-99.9%-53.1%-56.3%
-66.73----

The ratios are withheld because a balance sheet total of €2,893 is too small for a meaningful ratio.

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Insights on BIOFLOW

The operating result for 2021 is a loss of €7,918, larger than the loss of €448 in 2020.

Equity is negative. Debt (€39,427) exceeds the balance-sheet total (€2,893).